Click for bio
Scientific Director / Clear Cell Sarcoma Foundation
Kelley Argraves is deeply involved in the mission of Sara’s Cure. Kelley found a passion for science early in her schooling, but a direction into research emerged after she graduated from college and met her husband, Scott. Scott was starting his own lab and encouraged Kelley to go to graduate school and join him at the bench. After obtaining her Ph.D. in Biochemistry and Molecular Biology at The George Washington University, Kelley relocated from Maryland to Charleston and set up her own lab next door to Scott’s at the Medical University of South Carolina. In 2013, after many happy and productive years in collaboration, Scott was diagnosed with an aggressive brain tumor, glioblastoma. Unfortunately, Scott did not survive long after diagnosis, but Kelley and their two kids were surrounded with love and support by their best friends, Lennie and Denny Woods. After a few years researching solo, Kelley began to explore other career directions. Simultaneously, Sara Woods was diagnosed with CCS and it became clear that since there were no known treatments for this aggressive and rare cancer, they had to come together to push for research for treatments and a cure. Kelley has dedicated herself to making a difference for Sara and the others diagnosed with CCS.
Assistant Professor
Pediatric Hematology-Oncology
Seattle Children’s Hospital
bio coming soon.
Medical Oncologist
University of Michigan
Rogel Comprehensive Cancer Center
Rashmi Chugh is a medical oncologist at University of Michigan Rogel Comprehensive Cancer Center, specializing in the care of patients with sarcoma and connective tissue tumors. Her research focus is in the development of new therapies for patients with sarcoma. She serves as the co-lead of the Connective Tissue Research Team, co-Medical Director of the Michigan Adolescent and Young Adult Oncology Program, Associate Division Chief of Clinical Services for the Division of Hematology/Oncology, and is a member of the Scientific Steering Committee for the Sarcoma Alliance for Research through Collaboration. She received her medical degree at Washington University in St. Louis followed by her internal medicine and hematology/oncology training at University of Michigan.
Professor
Hematology-Oncology Assistant
Vanderbilt Ingram Cancer Center
Dr. Libby Davis is a medical oncologist who specializes in the treatment of patients with bone and soft tissue sarcoma at Vanderbilt University Medical Center (VUMC) in Nashville, Tennessee. She received her Bachelor of Science in biology from Duke University and her Doctor of Medicine degree from Wright State University School of Medicine. She then completed her Internal Medicine residency and Hematology-Oncology fellowship at the University of Michigan. Following completion of her training, she was a faculty member at the University of Michigan before moving to VUMC in 2016. She is a Co-director of the Young Adult Cancer Initiative at VUMC whose mission is to support and advance the care of young adults with cancer.Dr. Davis’s primary research interests involve improving the medical management of sarcoma patients through the creation of novel treatment regimens and early phase clinical trials. She is interested in understanding drug resistance to current agents and exploring how the genetic differences in sarcoma subtypes can guide the development of targeted therapy. She is also focused on improving outcomes for patients with sarcoma through studying the effect of changes in activity level, sleep, and body composition during sarcoma treatment. She serves as a principal investigator on numerous clinical trials and is an active member of the ECOG Sarcoma Working Group, the American Society for Clinical Oncology, the Connective Tissue Oncology Society, and the Sarcoma Alliance for Research through Collaboration.
Associate Professor
Pediatric Hematology / Oncology
Riley Children’s Health
Indiana University
Dr. Ferguson is a pediatric oncologist at Riley Hospital for Children in Indianapolis, IN specializing in the treatment of various sarcomas with a specific focus on soft tissue sarcomas. He currently serves as the Medical Director of both the Solid Tumor Program and also the Precision Genomics Program at Riley Hospital for Children. Dr. Ferguson attended the University of Notre Dame and obtained a B.S. in Premedical Studies. He obtained both a Master’s of Science in Cellular and Integrative Physiology and his Medical Degree at Indiana University School of Medicine. Dr. Ferguson additionally completed an NIH T32-funded Pediatric Clinical Pharmacology Fellow due to his interests in novel therapies and additionally a second Master’s of Science in Clinical Investigation both at Indiana University School of Medicine. His research looks into utilizing clinical tumor and germline genomics to investigate novel combinatorial therapies in patient-derived mouse models of various pediatric sarcomas. Dr. Ferguson additional serves as the Chair of the Professional Development Committee for the American Society of Pediatric Hematology Oncology (ASPHO) as his other passion is aiding fellows and junior faculty to help develop their careers.
Head of the Molecular and Systems Oncology Team
Division of Molecular Pathology Institute of Cancer Research, London
Paul Huang is Head of the Molecular and Systems Oncology Laboratory at The Institute of Cancer Research (ICR) in London, UK. He received his PhD in Biological Engineering from Massachusetts Institute of Technology in 2008. He is currently a tenured Faculty member within the Division of Molecular Pathology and holds a Cancer Research UK Career Establishment Award. His laboratory focuses on understanding aberrant signaling networks and drug resistance in sarcomas, with the goal of developing biomarkers and new therapies for these rare diseases. Paul is the Deputy Director of the Joint Royal Marsden-ICR Sarcoma Research Centre, one of the largest sarcoma research centres in Europe. He also serves as Vice Chair of the Pathology & Translational Research Committee of the EORTC Soft Tissue and Bone Sarcoma Group. He was elected a Fellow of the Royal Society of Biology in 2020.
Leader, Huntsman Cancer Inst. Sarcoma Disease CenterDivision Chief, Sarcoma dept. of Orthopedics Professor
Dept. of Orthopedics
After studying literature at Harvard, Medicine at Johns Hopkins, Orthopaedic Surgery at the University of Iowa, and Musculoskeletal Oncology at the University of Toronto, Kevin brought his wife and four children to Salt Lake City, Utah. While a faculty surgeon, he spent five years in a mentored position in the laboratory of Mario Capecchi. Now holding the L.B. and Olive S. Young Presidential Endowed Chair for Cancer Research in the Department of Orthopaedics, Dr. Jones provides surgical care for the full range of neoplastic diseases that afflict the musculoskeletal system in children and adults. His laboratory in the Department of Oncological Science at the Huntsman Cancer Institute studies the epigenetic regulation of transcription, using mouse models of translocation-associated sarcomas, especially synovial sarcoma, alveolar soft part sarcoma, and clear cell sarcoma.
Medical Oncologist
Head of the Sarcoma
Unit Royal Marsden, UKTeam Leader at ICR, London
Robin Jones is a medical oncologist specializing in the treatment of bone and soft tissue sarcomas and Head of the Sarcoma Unit at The Royal Marsden. He has experience in conducting Phase I, II and III trials, as well translational studies in sarcomas. Professor Jones trained in medical oncology at The Royal Marsden and between 2010 and 2014 he was Head of the Sarcoma Program at the University of Washington/Fred Hutchinson Cancer Research Center in Seattle.
Pediatric Oncologist Director Children’s Cancer Innovative Therapy Program
Cleveland Clinic,
Case Comprehensive Cancer Center
Matteo Trucco is a Pediatric Oncologist at the Cleveland Clinic, specializing in the care of children, teenagers and young adults battling bone and soft tissue cancers. He also directs the Children’s Cancer Innovative Therapy Program where he and colleagues design, develop and conduct clinical trials seeking more effective and less toxic treatments for childhood cancers. Dr. Trucco earned his undergraduate degree from the University of Pennsylvania and Medical Degree from Temple University School of Medicine. He completed his Pediatrics Residency at Rainbow Babies and Children’s Hospital and his Pediatric Hematology/Oncology Fellowship from Johns Hopkins and the National Cancer Institute. In addition to his roles at the Cleveland Clinic, he is a vice chair of the National Pediatric Cancer Foundation’s Sunshine Project consortium, partnering with other top pediatric cancer centers to develop clinical trials, and he is a member of the advisory board for a number of foundations dedicated to improving therapies for childhood cancers..
Assistant Professor of
Hematology/ Oncology
(sarcoma focus)
University of Kansas
Medical Center
I earned my medical degree from the University of Kansas School of Medicine, then completed internal medicine residency at Loyola University Medical Center back in Chicago. I returned to Kansas City again for my hematology/oncology fellowship at the University of Kansas Medical Center. I am certified by the American Board of Internal Medicine with sub certifications in hematology and medical oncology. In my clinical practice, I have specialized further into medical management of bone and soft tissue tumors, while also being involved in ongoing education/coaching/mentoring of first and second year medical students. I have a lovely wife and three active sons, and enjoy outdoor sports, barbecuing, traveling and reading.
